4th Quarter - Report

BAVARIAN NORDIC INC. for BAVARIAN NORDIC INC.

Firm
Client
Income
—
Expenses
$130,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Disaster Planning/Emergencies DIS

Biodefense; Biomedical Advanced Research and Development Authority funding; vaccine research, development, manufacturing and marketing; infectious diseases; PAHPA; Labor-HHS-ED appropriations bills; NDAA

Foreign entity interest: Bavarian Nordic A/S, a Danish company, is the parent company of Bavarian Nordic Inc.

LobbyistCovered position, as disclosed
LAURA EFROS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Homeland Security HOM

Biodefense; Biomedical Advanced Research and Development Authority funding; vaccine research, development, manufacturing and marketing; infectious diseases; PAHPA; Labor-HHS-ED appropriations bills; NDAA

Foreign entity interest: Bavarian Nordic A/S, a Danish company, is the parent company of Bavarian Nordic Inc.

LobbyistCovered position, as disclosed
LAURA EFROS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Science/Technology SCI

Biodefense; Biomedical Advanced Research and Development Authority funding; vaccine research, development, manufacturing and marketing; infectious diseases; PAHPA; Labor-HHS-ED appropriations bills; NDAA

Foreign entity interest: Bavarian Nordic A/S, a Danish company, is the parent company of Bavarian Nordic Inc.

LobbyistCovered position, as disclosed
LAURA EFROS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

Biodefense; Biomedical Advanced Research and Development Authority funding; vaccine research, development, manufacturing and marketing; infectious diseases; PAHPA; Labor-HHS-ED appropriations bills; NDAA

Foreign entity interest: Bavarian Nordic A/S, a Danish company, is the parent company of Bavarian Nordic Inc.

LobbyistCovered position, as disclosed
LAURA EFROS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Biodefense; Biomedical Advanced Research and Development Authority funding; vaccine research, development, manufacturing and marketing; infectious diseases; PAHPA; Labor-HHS-ED appropriations bills; NDAA

Foreign entity interest: Bavarian Nordic A/S, a Danish company, is the parent company of Bavarian Nordic Inc.

LobbyistCovered position, as disclosed
LAURA EFROS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medical/Disease Research/Clinical Labs MED

Biodefense; Biomedical Advanced Research and Development Authority funding; vaccine research, development, manufacturing and marketing; infectious diseases; PAHPA; Labor-HHS-ED appropriations bills; NDAA

Foreign entity interest: Bavarian Nordic A/S, a Danish company, is the parent company of Bavarian Nordic Inc.

LobbyistCovered position, as disclosed
LAURA EFROS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Defense DEF

Biodefense; Biomedical Advanced Research and Development Authority funding; vaccine research, development, manufacturing and marketing; infectious diseases; PAHPA; Labor-HHS-ED appropriations bills; NDAA

Foreign entity interest: Bavarian Nordic A/S, a Danish company, is the parent company of Bavarian Nordic Inc.

LobbyistCovered position, as disclosed
LAURA EFROS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.